Navigation Links
Clinical Study Demonstrates Superior Bioavailability of Jarrow's Proprietary QH-absorb Formula
Date:6/13/2009

href );" target="_blank" title="Kaneka Corporation">Kaneka Corporation, the world's largest manufacturer of CoQ10. The Kaneka production process yields Co-Q10 of the highest purity and potency available.

Jarrow Formulas® is a direct contributor to research on CoQ10. It has funded several clinical trials on the nutrient, as well as acts as a sponsor for the international society that promotes research and education regarding coenzyme Q10.

The suggested retail price (SRP) for Jarrow Formulas®' QH-absorb® products are as follows:

 
  • QH-absorb®, 60 softgels (30 mg): $21.95
  • QH-absorb®, 60 softgels (100 mg): $55.95
  • QH-absorb®, 30 softgels (200 mg): $49.95

Jarrow Formulas® is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the world, including the United States, Mexico, Canada, England, France, Japan, Singapore, China, Taiwan, Israel, Kuwait, Azerbaijan and other countries. The company offers a complete line of nutritional products that includes vitamins, minerals, specialty antioxidants, probiotics, amino acids, standardized herbal concentrates and enzymes. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain Americans' rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorpora
'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS
2. Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
3. Clinical Innovations Introduces New Circumcision Device
4. New Directions in Angioedema: A Focus on Etiologies and Clinical Approach
5. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
6. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
7. Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
8. Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
9. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
10. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
11. Ross University School of Medicine Expands Clinical Rotations in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014 For its December ... The AIS Report on Blue Cross and Blue Shield ... on the varied strategies the two Blues plans are ... with treatments for sleep apnea, ranging from brick-and-mortar retail ... it’s linked to increased rates of a variety of ...
(Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... Angeles orthopedic surgeon Dr. Steven Meier has enhanced ... to offer current and prospective patients an online destination ... “We’re really excited to present the new and improved ... added features make it easier than ever for current ...
(Date:11/26/2014)... November 26, 2014 GI for Life ... seen reductions in prices of their popular nutritional supplements: ... Vitamin D3 . Discounts of 40% will be ... GI for Life’s proprietary ColoVite supplement is a scientifically ... promote colon health. One easy-to-take colon vitamin with ALL ...
(Date:11/26/2014)... Sonru, the video interviewing specialist, has ... Officer and Chief Marketing Officer, in addition to the ... Jeff Jones has been appointed as Chief Operating Officer. ... role of Chief Marketing Officer. , Mr Jones is ... career includes senior roles with The Walt Disney Company ...
(Date:11/26/2014)... November 26, 2014 Anthropologists have ... in containing and stopping Ebola, improve international support, ... healthcare systems in West Africa. , The ... Stop Ebola: Anthropologists Offer Insights,” will be made ... American Anthropological Association (AAA), Fri., Dec. 5, 11 ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3
... AKRON, Ohio, Sept. 17 As the ... country, Summa Health System provides the following response to the latest ... As a system, Summa continues to inform the debate by sharing ... that would impact its patients, health in a positive way, including ...
... , , HARRISBURG, Pa., Sept. 17 ... at schools in Beaver and Erie counties has not detected unsafe ... said today. , , DEP,s investigation was prompted ... toxic air around the schools. , , DEP ...
... , , , SUNNYVALE, Calif., ... financial results for its fourth quarter and fiscal year ended June 30, 2009. ... loss of $5.4 million, or $0.20 per share, compared to a net loss ... 2008. , , Total non-GAAP net loss for the quarter ...
... NORCROSS, Ga., Sept. 17 Immucor, Inc. (Nasdaq: ... the blood transfusion industry, today announced that it will release its ... the market close. The Company will host a conference call on ... the results. , , Investors are ...
... , , ... Food and Drug Administration (FDA) has approved Valturna((R)) (aliskiren and valsartan) ... within the renin system, also known as the renin angiotensin aldosterone ... first approval for Valturna, which is indicated for the treatment of ...
... are still too low, CDC report finds , THURSDAY, Sept. ... the United States are gaining ground, there is still a ... of 90 percent coverage, a new government report shows. , ... for measles-mumps-rubella and Hepatitis B vaccinations among teens aged 13 ...
Cached Medicine News:Health News:Ohio Healthcare Organization Responds to Healthcare Reform 2Health News:Ohio Healthcare Organization Responds to Healthcare Reform 3Health News:Ohio Healthcare Organization Responds to Healthcare Reform 4Health News:Ohio Healthcare Organization Responds to Healthcare Reform 5Health News:Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 2Health News:Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 3Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 2Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 3Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 4Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 5Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 6Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 7Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 8Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 9Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 10Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 11Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 12Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 13Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 14Health News:Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 15Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 2Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 3Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 4Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 5Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 6Health News:Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 7Health News:More Teens Getting Needed Vaccines 2
(Date:11/26/2014)... YORK , Nov. 26, 2014 ... growing at a rate of 4%, with world ... to Kalorama Information. MRI and other types of ... diagnosis and treatment of numerous medical conditions in ... technologies and techniques. Kalorama,s report, Medical Imaging ...
(Date:11/26/2014)... FRANCISCO , Nov. 25, 2014  goBalto, Inc., ... has been recognized as a winner of Red Herring,s ... a Global Top 100 North America award in 2013, ... international technology landscape. Red Herring,s Top 100 ... identifying promising new companies and entrepreneurs. Red Herring editors ...
(Date:11/26/2014)... Nov. 25, 2014   Heska Corporation (NASDAQ: ... "Company"), a provider of advanced veterinary diagnostic and other ... , Executive Chair, will attend The Benchmark Company, LLC,s Micro ... conference will be held at The Palmer House Hilton, 17 ... 8 a.m. to 2:30 p.m. Please email hska@haydenir.com ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... , March 15 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ... a conference call at 10:00 a.m. Eastern Time ... financial results for the first quarter,of its fiscal year ...
... announced today that it has finalized an amendment to its loan and security agreement with Silicon Valley Bank.  The amendment extends the ... to obtain additional funds if necessary. , ... , ... ...
Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 3Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 2Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 3
Automated QC module...
... The FLEXLINK software links ... at the bedside, making data ... eliminating the risk of incorrect ... is part of 1st automatic, ...
... is a unique tool that ... commands to activate shortcut keys ... the need to perform manual ... can devote your full attention ...
... Manometry Application for POLYGRAM NET™ (PNET) ... recorder to record and analyze pressure, ... esophageal manometry procedures. The PNET software ... solid-state or water-perfused manometry catheters and ...
Medicine Products: